Investor Relations
The Leader in Brachytherapy
Isoray advances innovative radiotherapeutic technologies that focus on the patient.
Latest Results
Isoray Announces Second Quarter Fiscal 2020 Financial Results
Revenue Increased 16% Year-Over-Year Gross Profit Increased 45% Year-Over-Year RICHLAND, WASHINGTON – February 11, 2020 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options...
Isoray Announces Record First Quarter Fiscal 2020 Financial Results
Record Revenue and Gross Profit Revenue Increased 48% Year-Over-Year RICHLAND, WASHINGTON – November 12, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the...
Isoray Announces Fourth Quarter and Full-Year Fiscal 2019 Financial Results
Record Full Year Revenue Driven by 27% Growth in the Company’s Core Prostate Brachytherapy RICHLAND, WASHINGTON – September 24, 2019 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment...
Isoray Announces Record Third Quarter Fiscal 2019 Financial Results
Record Revenue and Gross Profit Revenue Increased 22% Year-Over-Year RICHLAND, WASHINGTON – May 9, 2019 -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body,...
Isoray Announces Second Quarter Fiscal 2019 Financial Results
Record Revenue and Gross Profit Revenue Increased 24% Year-Over-Year RICHLAND, WASHINGTON - February 12, 2019 -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout...
Investor Resources
Research Analyst Coverage
Ascendiant Capital Markets
Edward Woo
Dawson James Securities Inc.
Jason Kolbert
H.C. Wainwright & Co.
Swayampakula Ramakanth, Ph.D.
Do you have questions?
We’ll put you in touch with someone to answer any of your investor related questions.
Investor Relations:
Mark Levin
Global IR Group
mark@globalirgroup.com
Our Management Team
Learn more about our experienced management team who are focused on growth.
Investor News Alerts
Use the button below to email us and receive the latest investor focused news from Isoray.